Search research articles
Contact Us
Filters
Showing results (41-50 of 638) with videos related to
Page
of 64
Sort By:
Expert Review of Gastroenterology & Hepatology
|
July 31, 2015
Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications
Luca Miele, Giovanni Targher
Annals of Translational Medicine
|
November 9, 2019
Are we overrating the extra-skeletal benefits of oral vitamin D supplementation?
Giuseppe Lippi, Giovanni Targher
Gut
|
October 20, 2020
NAFLD-related mortality: simple hepatic steatosis is not as 'benign' as thought
Herbert Tilg, Giovanni Targher
Current Pharmaceutical Design
|
May 1, 2020
NAFLD in the 20's. From Epidemiology to Pathogenesis and Management of Nonalcoholic Fatty Liver Disease
Amedeo Lonardo, Giovanni Targher
Annals of Translational Medicine
|
August 1, 2017
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani, Giovanni Targher
Nature Reviews. Gastroenterology & Hepatology
|
May 9, 2012
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
Enzo Bonora, Giovanni Targher
Alimentary Pharmacology & Therapeutics
|
March 29, 2019
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease
Giovanni Targher, Giuseppe Lippi
Kardiologia Polska
|
June 26, 2019
Increased red blood cell distribution width and platelet‑to‑lymphocyte ratio for predicting all‑cause mortality in patients with type 2 diabetes and advanced heart failure: a causal association or epiphenomenon?
Giuseppe Lippi, Giovanni Targher
Pediatric Diabetes
|
December 7, 2010
A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties?
Giuseppe Lippi, Giovanni Targher
Diabetes Care
|
September 19, 2025
Response to Comment on Mantovani et al. Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies. Diabetes Care 2025;48:1042-1052
Alessandro Mantovani, Giovanni Targher
Page
of 64
Search research articles
Search
Showing results (41-50 of 638) with videos related to
Sort By:
Page
of 64
Expert Review of Gastroenterology & Hepatology
|
July 31, 2015
Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications
Luca Miele, Giovanni Targher
Annals of Translational Medicine
|
November 9, 2019
Are we overrating the extra-skeletal benefits of oral vitamin D supplementation?
Giuseppe Lippi, Giovanni Targher
Gut
|
October 20, 2020
NAFLD-related mortality: simple hepatic steatosis is not as 'benign' as thought
Herbert Tilg, Giovanni Targher
Current Pharmaceutical Design
|
May 1, 2020
NAFLD in the 20's. From Epidemiology to Pathogenesis and Management of Nonalcoholic Fatty Liver Disease
Amedeo Lonardo, Giovanni Targher
Annals of Translational Medicine
|
August 1, 2017
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani, Giovanni Targher
Nature Reviews. Gastroenterology & Hepatology
|
May 9, 2012
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
Enzo Bonora, Giovanni Targher
Alimentary Pharmacology & Therapeutics
|
March 29, 2019
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease
Giovanni Targher, Giuseppe Lippi
Kardiologia Polska
|
June 26, 2019
Increased red blood cell distribution width and platelet‑to‑lymphocyte ratio for predicting all‑cause mortality in patients with type 2 diabetes and advanced heart failure: a causal association or epiphenomenon?
Giuseppe Lippi, Giovanni Targher
Pediatric Diabetes
|
December 7, 2010
A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties?
Giuseppe Lippi, Giovanni Targher
Diabetes Care
|
September 19, 2025
Response to Comment on Mantovani et al. Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies. Diabetes Care 2025;48:1042-1052
Alessandro Mantovani, Giovanni Targher
Page
of 64